Q32 Bio Inc. (FIXX) Operating Income (Loss) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Q32 Bio Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
  • Q32 Bio Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$14.8 M, a 101% decline year-over-year.
  • Q32 Bio Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$109 M, a 5.69% decline year-over-year.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2023 was -$101 M, a 23.9% increase from 2022.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2022 was -$133 M, a 38.9% decline from 2021.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2021 was -$95.9 M, a 26.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$109 M -$14.8 M -$7.47 M -101% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$101 M -$32.2 M +$2.26 M +6.54% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$104 M -$31 M +$1.86 M +5.66% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$106 M -$30.8 M -$2.51 M -8.86% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$103 M -$7.37 M +$30.2 M +80.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$133 M -$34.5 M -$869 K -2.58% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$132 M -$32.9 M -$2.2 M -7.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$130 M -$28.3 M +$2.25 M +7.35% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$132 M -$37.6 M -$36.5 M -3286% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$95.9 M -$33.6 M -$3.82 M -12.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$92.1 M -$30.7 M -$2.39 M -8.45% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$89.7 M -$30.6 M +$5.15 M +14.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$94.9 M -$1.11 M +$35.4 M +97% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$130 M -$29.8 M -$4.24 M -16.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$126 M -$28.3 M +$3.02 M +9.64% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$129 M -$35.7 M -$7.72 M -27.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$121 M -$36.5 M -$11.4 M -45.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$110 M -$25.6 M -$5.39 M -26.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$105 M -$31.3 M -$15.7 M -100% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$88.9 M -$28 M -$14.6 M -108% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$74.4 M -$25.1 M -$14.4 M -135% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$59.9 M -$20.2 M -$7.91 M -64.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$52 M -$15.6 M -$8.97 M -135% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$43 M -$13.4 M -$7.38 M -122% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$35.7 M -$10.7 M -$6 M -128% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$29.7 M -$12.3 M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$6.66 M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$6.04 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$4.69 M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.